Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 06, 2016 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Independent evaluation confirms early promising signs of efficacy in the phase I/II bile duct cancer study

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 6 September 2016 - PCI Biotech...
September 05, 2016 08:41 ET | Source: PCI Biotech Holding ASA

PCI Biotech: First subject dosed in the fimaVACC phase I study

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 5 September 2016 - PCI Biotech...
September 01, 2016 05:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech and BioNTech initiates preclinical research collaboration

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 1 September 2016 - PCI Biotech...
August 30, 2016 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Second quarter and first half year 2016 results

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 30 August 2016. Please find...
August 29, 2016 15:48 ET | Source: PCI Biotech Holding ASA

PCI Biotech granted Orphan Drug Designation of fimaporfin for treatment of cholangiocarcinoma in EU

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 29 August 2016 - PCI Biotech...
August 24, 2016 04:07 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Invitation to second quarter and first half year 2016 presentation

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 24 August 2016 - PCI Biotech...
July 28, 2016 02:31 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Publication of the fimaporfin (Amphinex) first-in-man Phase I study in Lancet Oncology

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 28 July 2016 - PCI Biotech (PCIB) a...
July 25, 2016 14:46 ET | Source: PCI Biotech Holding ASA

PCI Biotech receives positive opinion for Orphan Drug Designation of fimaporfin for treatment of cholangiocarcinoma in EU

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 25 July 2016 - PCI Biotech (OSE:...
May 26, 2016 02:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Pre-clinical research collaboration agreement with top-10 large pharma company extended

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, May 26, 2016 - PCI Biotech reported...
May 19, 2016 06:38 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Minutes from Annual General Meeting 2016

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Oslo, 19 May 2016. The Annual General...